Copyright © Meta Pharmaceuticals Inc.
In May 2022, the 10th “Dongsheng Cup” International Entrepreneurship Competition was launched, drawing 1,852 innovative and entrepreneurial projects from three major industries: life sciences, digital economy, and new energy/new materials. These projects spanned 96 countries and cities worldwide.After intense competition, META Pharmaceuticals emerged victorious, receiving the prestigious Global Excellence Award in the 10th “Dongsheng Cup” International Entrepreneurship Competition 2022. Notably, META Pharmaceuticals was the sole company in Shenzhen, China to achieve this honor.
As the recipient of the Global Excellence Award, META Pharmaceuticals was also granted a prize package that includes:
- 10,000 RMB
- 5 free spaces
- “Hummingbird Program” acceleration package
This recognition and support from the event organizer are aimed at empowering global entrepreneurs across multiple dimensions.
Located in Shenzhen, China, META Pharmaceuticals is the first commercialization company in China to focus on the emerging field of immunometabolism in order to develop first-in-class original drugs in immunometabolism. The founding team is mainly from the top research hospitals in the US: Cornell University Medical College and Memorial Sloan Kettering Cancer Center. The founders have been engaged in related biological basic theory research for nearly 10 years, and have been committed to exploring the biological mechanism of mutual regulation between immune cells and nutrient metabolism, and breakthroughs in the discovery of therapeutic strategies that can be used to achieve immune system function regulation by modulating the metabolic vitality of immune cells. In June of this year, the company completed its seed and Pre-A rounds of financing, totaling hundreds of millions of RMB, led by Forcefield Ventures, XtalPi Inc., IMO Ventures, and Tiantu Capital.
The “Dongsheng Cup International Entrepreneurship Competition” is a global innovation and entrepreneurship competition. It is jointly guided by the Beijing Municipal Bureau of Human Resources and Social Security, the Beijing Municipal Science and Technology Commission, the Zhongguancun Science and Technology Park Management Committee, the Beijing Haidian District People’s Government, and the Zhongguancun Science Park Management Committee. The competition is also co-sponsored by the Beijing Municipal Employment Promotion Center, the Beijing Municipal Bureau of Human Resources and Social Security of Haidian District, and the Zhongguancun Dongsheng Science and Technology Park Management Committee.
Launched in 2013, the competition has been successfully held nine times, attracting a total of 11,306 outstanding entrepreneurial projects both at home and abroad. This includes more than 2,500 overseas projects. The focus has been on the follow-up and incubation of over 2,000 projects. Additionally, the competition has provided a total of over 30,000 instances of science and technology creation services. These services encompass seven dimensions: training and coaching, financial services, branding, policy consulting, resource docking, space support, and human resources services. These efforts are facilitated through the “Co-Respondent Hummingbird Program” for innovative projects. The overarching goal is to create a comprehensive science and technology ecosystem, serving as a one-stop platform for global innovation and entrepreneurial dynamics. This platform brings together cutting-edge science and technology with robust entrepreneurial support.